Autolus Therapeutics plc (FRA:6A3A)
Germany · Delayed Price · Currency is EUR 1.480
-0.120 (-7.50%)
Last updated: Jun 3, 2026, 8:10 AM CET
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of €399.99 million as of June 3, 2026. Its market cap has increased by 25.94% in one year.
Market Cap
399.99M
Enterprise Value
507.51M
Revenue
80.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.48
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from 833.42M to 399.99M, a decrease of -52.01%. That is a compound annual growth rate of -8.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 399.99M | -11.33% |
| Dec 31, 2025 | 451.08M | -25.33% |
| Dec 31, 2024 | 604.06M | -40.39% |
| Dec 29, 2023 | 1.01B | 229.38% |
| Dec 30, 2022 | 307.67M | -7.54% |
| Dec 31, 2021 | 332.77M | -12.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.27B |
| Darwin AG | 72.00M |
| 2invest AG | 45.07M |
| Biomark Diagnostics | 36.15M |
| Vidac Pharma Holding | 29.43M |
| Paion AG | 403.05K |
| co.don AG | 347.40K |
| bioXXmed AG | 217.49K |